<code id='9E30DB54F6'></code><style id='9E30DB54F6'></style>
    • <acronym id='9E30DB54F6'></acronym>
      <center id='9E30DB54F6'><center id='9E30DB54F6'><tfoot id='9E30DB54F6'></tfoot></center><abbr id='9E30DB54F6'><dir id='9E30DB54F6'><tfoot id='9E30DB54F6'></tfoot><noframes id='9E30DB54F6'>

    • <optgroup id='9E30DB54F6'><strike id='9E30DB54F6'><sup id='9E30DB54F6'></sup></strike><code id='9E30DB54F6'></code></optgroup>
        1. <b id='9E30DB54F6'><label id='9E30DB54F6'><select id='9E30DB54F6'><dt id='9E30DB54F6'><span id='9E30DB54F6'></span></dt></select></label></b><u id='9E30DB54F6'></u>
          <i id='9E30DB54F6'><strike id='9E30DB54F6'><tt id='9E30DB54F6'><pre id='9E30DB54F6'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:explore    Page View:78476
          Mayo Clinic, in Rochester, Minnesota on
          Photo by KEREM YUCEL/AFP via Getty Images

          SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

          The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

          advertisement

          With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          At least 12 people were injured in a blast at a port in northwest Turkey
          At least 12 people were injured in a blast at a port in northwest Turkey

          1:27Catchuponthedevelopingstoriesfromaroundtheglobemakingheadlines.ISTANBUL--Anexplosionataportinnor

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Biden declares emergency in flood

          LiveAgeneralviewofafloodedarea,inLudlow,Vt.,July10,2023.Instagram@henrysweatherchannel/viaReutersU.S